Tze-Chiang Meng is a notable inventor based in Lino Lakes, MN, who has made significant contributions to the field of dermatology. He holds a total of seven patents, focusing primarily on innovative treatments for actinic keratosis. His work aims to improve patient outcomes through more effective and convenient dosing regimens.

Latest Patents

Among his latest patents, Meng has developed a 2x2x2 week dosing regimen for treating actinic keratosis using pharmaceutical compositions formulated with 3.75% imiquimod. This innovation includes pharmaceutical formulations and methods for the topical or transdermal delivery of imiquimod, specifically designed to treat actinic keratosis with shorter therapy durations compared to the currently prescribed Aldara® 5% imiquimod cream. His formulations focus on delivering an efficacious dose of imiquimod while maintaining an acceptable safety profile, making treatment more convenient for patients.

Career Highlights

Tze-Chiang Meng is associated with Medicis Pharmaceutical Corporation, where he continues to advance his research and development efforts. His work has been instrumental in creating more effective treatment options for patients suffering from actinic keratosis.

Collaborations

Meng has collaborated with notable colleagues, including Michael T Nordsiek and Sharon F Levy, to further enhance the development of his innovative treatments.

Conclusion

Tze-Chiang Meng's contributions to the field of dermatology, particularly in the treatment of actinic keratosis, highlight his commitment to improving patient care through innovation. His patents reflect a significant advancement in pharmaceutical formulations, paving the way for more effective and convenient treatment options.

This text is generated by artificial intelligence and may not be accurate.